NCT07044310View on ClinicalTrials.gov

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

PHASE2RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

July 25, 2027

Study Completion Date

July 25, 2027

Conditions
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Hormone Receptor-Positive Breast Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Bone Mineral Density Test

Undergo BMD

OTHER

Questionnaire Administration

Ancillary studies

DRUG

WBF-038

Given WBF-038 PO

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER